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Infection after Surgery
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Abstract
Obesity is a prevalent health problem all over the world. It is associated with 
several diseases including infections. It impairs the immune system function by 
plenty of mechanisms. For instance, leptin and adiponectin are cytokines produced 
by the adipose tissue, both participating in immunity, but their effects are impaired 
in obese patients. Moreover, immune cells also show defects in their functions. They 
produce a pro-inflammatory state and contribute to obesity-related diseases. Innate 
immune system and adaptive immunity are both impaired in obese patients which 
causes a poor response to infections. In addition, in surgical site infections (SSI), 
there are local factors that must be considered. The large adipose panicle and vis-
ceral adipose tissue increase the surgical technique difficulty and extend the opera-
tive time. Besides, the adipose tissue has poor oxygenation and reduces operative 
field. It has been proven that obesity is associated to surgical site infection irrespec-
tive of type of surgery. However, minimal invasive surgery has demonstrated that 
reducing surgical trauma can diminish the risk for surgical site infection.
Keywords: obesity, surgery, surgical site infection, immune deficiency,  
surgical complication
1. Introduction
Nowadays, obesity is a serious health problem which affects all countries 
irrespective of economic status. It is produced by an energy imbalance, and then 
there is an increase in body-fat mass. A body mass index (BMI) more than 30 kg/m2 
is defined as obesity [1].
There are plenty of diseases that are linked to obesity; the most common are 
metabolic syndrome, type 2 diabetes mellitus, coronary disease, and hyperlipid-
emia. Despite not being as well-known as the previous examples, obesity is strongly 
associated with infection [2].
Obese patients have a higher risk of nosocomial infections because medical care 
of these patients requires special procedures, equipment, and staff. Moreover, obese 
patients are usually immobilized which is a risk factor for decubitus ulcers and 
contributes to increase length of stay [3].
Although there are some controversial studies, an association between caries 
rates and elevated BMI has been proven. Dietary habits characterized by high 
consumption of soft drinks, fast food, and refined sugar contribute to dental caries 
as well as obesity [4]. In addition, it is well-known that severe infections in the face 
and neck usually have an odontogenic origin and obesity is a risk factor for the 
infection progression. Besides, an association has been described between the levels 
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of tumor necrosis factor alpha in gingival crevicular fluid and BMI [5]; therefore, 
there is a systemic effect of obesity in oral health.
Obesity is related to respiratory diseases including nosocomial pneumonia and 
community-acquired respiratory tract infections [3]. In these patients, a decreased 
lung volume and a restrictive ventilatory pattern have been noticed. Excess weight 
on the anterior chest wall, abdominal obesity, and the presence of the adipose tissue 
in the intra-abdominal visceral tissue increase muscle work in breathing, diminish 
lung expansion, and increase airway resistance. These mechanical changes and aug-
mented adipose tissue produce an inflammatory state that contributes to metabolic 
disease [6]. Other respiratory diseases associated to obesity are obstructive sleep 
apnea, chronic obstructive pulmonary disease, and asthma [6, 7].
On the other hand, obesity is a risk factor for the development of steatosis 
in patients with chronic hepatitis C infection and biliary disease with infectious 
complications [3]. Skin and soft tissue infections are also more prevalent in obese 
patients [2, 3]. The adipose tissue affects the pharmacokinetics and pharmacody-
namics of antibiotics. Therefore, some special considerations must be taken when 
treating an obese patient [8, 9].
Even though there are some important studies that demonstrate obesity is not 
a risk factor for surgical complications [10], there are still some evidence that 
contrast with these researches [11]. On the other side, it is well-known that obese 
patients have a higher risk for surgical site infections (SSI) particularly when 
open surgery is performed. This phenomenon has been associated to low oxygen 
tension in the adipose tissue as well as a poor immune response observed in obese 
patients [3, 10, 11].
In this chapter we will review the available evidence about obesity as a risk factor 
for surgical infections in most common surgical procedures, considering patho-
physiology as well as relevant clinical information.
2. Pathophysiology of infection in obese patients
There are several mechanisms that cause immune dysfunction in obese patients. 
The adipose tissue produces some cytokines which have effects on immune cells. There 
are other mechanisms that explain the altered immune response in obese patients.
2.1 Leptin and adiponectin
Nowadays, it is well-known that the adipose tissue has an active role in immunity 
by producing factors like leptin and adiponectin [3].
Leptin influences hematopoiesis, angiogenesis, and immune homeostasis. It 
stimulates proliferation and activation of monocytes in vitro and also increases 
the expression of surface markers. Leptin affects maturation of dendritic cells; 
deficiency of this cytokine is related to lower levels of tumor necrosis factor alpha 
and interleukins 12 and 6. It prevents neutrophil apoptosis and stimulates their 
chemotaxes. Leptin affects immune function of natural killer (NK) cells and T cells. 
It promotes T-cell proliferation, cytokine secretion, and migration of these cells. 
Th1-cell immune response is also stimulated by leptin. In addition, B lymphocytes 
are affected by leptin. It controls their development and can augment their popula-
tion by suppressing apoptosis and stimulating proliferation of these cells [12–14]. 
Leptin also plays a role in wound healing. An experimental study has proved that 
leptin accelerates skin wound healing by increasing proliferation and differentiation 
of epidermal keratinocytes as well as promoting angiogenesis [15].
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Congenital leptin deficiency is rare in humans. Diet-induced obesity is related 
to high levels of circulating leptin; however, it has been hypothesized that obesity 
causes some resistance in leptin receptors similar to what happens with insulin 
resistance [16]. Therefore, in obese patients, leptin cannot produce its effect on the 
immune system despite high levels of this cytokine.
Adiponectin is another important circulating adipocytokine that plays a role in 
immunity. It has anti-angiogenic, anti-inflammatory, and anti-apoptotic effects. 
Adiponectin can inhibit the phagocytic activity of macrophages, reduce the produc-
tion of tumor necrosis factor alpha and gamma interferon, as well as induce the 
production of interleukin 10 and interleukin 1 receptor antagonists which are anti-
inflammatory molecules. However, serum/plasma levels of adiponectin are higher 
in immune-mediated diseases [17, 18]. In contrast, in obese patients, adiponectin 
levels are lower than controls, and it has been observed that production of this 
adipocytokine increases after weight loss [19].
2.2 Immune cells
Although, in diabetic patients, neutrophils show defects in their functions, in 
obese patients this phenomenon has not been noticed. Indeed, these cells seem 
to be chronically primed and contribute to the development of obesity-related 
diseases [1].
Monocytes and macrophages also take part in immune response. They can 
change their phenotype getting a pro-inflammatory form (M1 CD11c+) or an 
anti-inflammatory form (M2 CD11c-) [1]. In obesity, a pro-inflammatory state, 
adipose tissue macrophages are more prevalent, these cells have M1 phenotype and 
are considered a factor that increases sepsis mortality. In addition, the percentage of 
macrophages in the adipose tissue is directly proportional to the adipocyte size [20]. 
Current evidence suggest that overnutrition causes adipocyte hypertrophy which 
leads to hypoxia and stimulates macrophage activity [21].
Natural killer cells are lymphocytes of the innate immune system. They are 
defined as CD3-/CD56+ granular lymphocytes and can be subcategorized based on 
the level of CD56 expression. CD56dim NK cell (or low density) subset can produce 
granzymes and perforins and is more cytotoxic than CD56bright (or high density) 
subset. On the other way, CD56bright NK cells have immunoregulatory effects. In 
obesity, there is no clear consensus about the effects on peripheral NK cell num-
ber. However, there is a study that demonstrates a significant more prevalence of 
CD56bright NK cells in obese patients as well as these patients also show a decreased 
percentage of CD56dim NK cells. Therefore, the predominance of CD56bright NK 
cells could be a cause for the impaired lytic activity NK cells against virus-infected 
and tumor cells observed in obese patients [22]. Several other studies have shown 
the impact of obesity on NK cells. An increased expression of activation markers 
such as CD69 and a decreased expression of other molecules such as NKp30 and 
NKp44 have been observed. Moreover, NK cells isolated from obese patients fail 
to engage glycolytic metabolism. They also lose the ability to kill macrophages 
and augment expression of gamma interferon which stimulates the migration of 
macrophages [23].
Dendritic cells (DCs) are also affected by obesity. They can activate or sup-
press immune responses and are characterized as conventional, inflammatory, 
or plasmacytoid dendritic cells. An increase in inflammatory DCs in the adipose 
tissue has been described. These cells are created from inflammatory monocytes 
and contribute to adipose tissue inflammation. However, there is evidence suggest-
ing that conventional dendritic cells also take part in adipose tissue inflammation. 
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In addition, this study points out that dendritic cells could act independently of 
monocytes [24]. On the other hand, in obesity DCs failed to upregulate CD83, a 
marker for maturity. Besides, they produce less IL-12 and more IL-10, suggesting an 
inability to stimulate T cells [25].
Adaptive immunity is impaired too. Gamma delta T cells, a subset of T cells 
that takes part in repairing tissue and inducing inflammation, are diminished 
in obese patients and secrete less gamma interferon, contributing to the per-
sistence of chronic, non-healing wounds [1, 26]. On the other side, memory T 
cells in the adipose tissue overexpress some cytokines while underexpress other 
ones. Moreover, obesity increases memory T-cell number which can be related 
to leptin production. Under healthy circumstances, memory T cells contribute 
to control infections; however, they can also mediate the pathogenesis in other 
conditions such as obesity [27]. In contrast, the number of regulatory T cells is 
reduced in the adipose tissue which promotes inflammation and insulin resis-
tance [1, 26] because these cells participate actively maintaining self-tolerance 
and suppressing activity of effector T cells. This reduction can be partially 
explained by the levels of leptin which decreases the proliferation of regula-
tory T cells [28]. Other affected T cells are Th1 and Th17 cells. The first ones are 
increased in the visceral adipose tissue of obese patients contributing to inflam-
mation, whereas Th17 cells are increased in the subcutaneous adipose tissue of 
obese patients and produce IL-17 which promotes inflammation and insulin 
resistance as well [26].
Relating to humoral immunity, there is no clear consensus. However, there is 
some evidence that it is impaired in obese patients. Obesity induces pro-inflam-
matory B cell subsets [29]. In spite of hyperstimulation of B cells and increased 
number of these, they function suboptimally and antibody production is modified. 
The most important factors that influence B-cell antibody production are leptin 
effect and essential fatty acid status [30].
3. Obesity and infection after surgery
Surgical site infection (SSI) is a serious complication that increases morbid-
ity and mortality as well as extends postoperative stay and rises healthcare costs. 
Indeed, one observational study performed in 7020 patients who underwent colon 
surgery finds an increased rate of SSI in obese patients (14.5% vs. 9.5%; p < 0.001). 
In this study SSI increases costs in $17,000 because these patients have longer stays 
and higher rates of hospital readmission [31]. This increased risk for SSI is espe-
cially noticeable in clean and clean-contaminated surgeries. In addition, a study 
described a relation between BMI and the risks for SSI, and then overweight could 
just be a risk factor for SSI in some kinds of surgery [32].
There are several mechanisms that explain this increased risk. Some of them 
have already been mentioned. However, there are other ones that are important in 
surgical site infection. The most important factor is hypoperfusion of adipose tissue 
which is due to less vascularization of adipose tissue. It causes poor tissue oxygen-
ation and extends wound healing. Moreover, there is more dead space, and antibiot-
ics might not get adequate concentrations in the wound [32, 33].
Other important factors are related to surgery. Obese patients have great adipose 
panicle which makes open surgery more difficult. In addition, the visceral abdomi-
nal tissue is also increased and obligates surgeons to take special considerations 
on the surgical technique such as longer incisions, prolonged surgery time, and 
increased mean operative blood loss [32, 33]. Both are known risk factors for surgi-
cal site infection.
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3.1 Obesity and gastrointestinal surgery
A large study performed in the Netherlands evaluated the relation between 
obesity and several types of surgery. Laparoscopic appendectomy, laparoscopic 
cholecystectomy, open colectomy, and laparoscopic colectomy were considered 
gastrointestinal surgery. The study revealed that the risk of superficial SSI gradually 
increased with increasing BMI, except in laparoscopic appendectomy. However, 
deep SSI did not seem related to BMI [32].
A meta-analysis also showed that overweight and obese patients have a 1.2- to 
1.5-fold higher odds of developing SSI after colorectal surgery. Moreover, the same 
study performed a subgroup analysis that included only elective surgery cases, and 
then the results were similar. The authors highlighted the suboptimal tissue concen-
trations of antibiotics in obese patients. It is not only related to the increased volume 
of distribution and altered plasma protein binding; indeed, obese patients have 
changes in hepatic metabolism and renal excretion, and the prevalence of diabetes 
is higher in these patients [34].
Another study performed a separate analysis for right colectomy, left colectomy, 
and rectal resection. Obesity did not affect morbidity and mortality after right col-
ectomy. However, the rate of postoperative intra-abdominal collections was higher 
in obese patients after left colectomy. Moreover, the study showed that obesity was 
a risk factor for anastomotic leakage after rectal resection. Therefore, the authors 
recommended the use of a defunctioning stoma in obese patients when diabetes or 
ASA > 2 is present [35].
On the other hand, laparoscopic surgery has brought to table other consider-
ations. A meta-analysis showed that the incidence of SSI is significantly less after 
laparoscopic surgery than after open surgery (70–80% lower risk). These find-
ings could be related to less surgical trauma and smaller incisions that are used in 
laparoscopic surgery. However, conversion to open surgery has the worst outcomes 
[36]. Despite the advantages of laparoscopic surgery, it is not always easy to perform 
it in obese patients. A meta-analysis demonstrated that visceral obesity is associ-
ated to longer operative time, less lymph node harvest, and higher conversion 
rate. Moreover, laparoscopic surgery in obese patients requires technical expertise 
because of the limited exposure of the surgical field and the thickened mesentery 
which is difficult to maneuver [37].
In obese children the problem is similar, and there is some evidence that dem-
onstrates that laparoscopy is safe in these patients, although it is related to longer 
operative time [38].
Laparoscopic surgery is safe in obese patients. However, there are some special 
considerations: adequate position to expand the surgical field avoiding pressure 
sores and minimizing nerve compression, adequate entry technique, longer opera-
tive time, and thromboprophylaxis [39].
Although there are few studies about obesity and robotic surgery, it has been sug-
gested that it could bring more benefits for obese patients. It has been observed that 
the length of stay and 30-day readmission rate were lower in patients who underwent 
robotic surgery than in patients who underwent laparoscopic surgery. It probably 
happens because of superior stable 3D views and ergonomic wristed instruments 
that robotic surgery offers [40]. However, it must be considered that robotic surgery 
is more expensive than laparoscopic surgery and requires appropriate training.
3.2 Obesity and gynecological surgery
In gynecological surgery there is some controversy. Overweight could be a 
protective factor for SSI in vaginal hysterectomy. However, there is an increased 
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risk for deep SSI in morbidly obese patients [32]. In abdominal hysterectomy, the 
findings are similar, and the risk for SSI increases linearly with increasing BMI. The 
same study showed a nonsignificant prevalence of Enterobacteriaceae in obese or 
overweight patients with SSI after abdominal hysterectomy [33].
A large study that included 18,810 patients who underwent hysterectomy for 
benign indications demonstrated that the risk for superficial and deep wound infec-
tion was higher with increasing BMI after total abdominal hysterectomy. However, 
the risk was not different when minimally invasive surgery (total vaginal hysterec-
tomy, laparoscopic assisted vaginal hysterectomy, total laparoscopic hysterectomy) 
was performed. In contrast, the operative time was longer with increasing BMI 
irrespective of the surgical approach [41].
Obesity is a risk factor for leiomyomata, ovulatory dysfunction, and endometrial 
cancer. All of them are common indications for hysterectomy. Therefore, hyster-
ectomy is a common surgical procedure performed in obese women. In that way, it 
is recommended to prefer a minimal invasive approach because of its reduced rate 
of complications. Other aspects to be considered are adequate thromboembolism 
prophylaxis, antibiotic prophylaxis, and adequate surgical technique [42].
In cesarean section, maternal obesity is also associated with surgical and postop-
erative risks such as endometritis, intra-abdominal collection, and surgical wound 
complications. In that way, antibiotic prophylaxis in these patients is different, and 
the actual recommendation is to administer at least 2 g of cefazolin some 60 min-
utes before the cesarean section. Another recommendation is to close the subcuta-
neous tissue layer in obese patients particularly when its depth exceeds 2 cm [43].
Finally, for mastectomy and lumpectomy, it has been observed that the risk of 
developing SSI augmented with increasing BMI. Moreover, obesity is a risk factor 
for major and minor complications after mastectomy irrespective of being unilat-
eral or performing reconstruction [44].
3.3 Obesity and orthopedic surgery
Obesity is an important risk factor for SSI after total hip prosthesis. It has been 
observed that the rate of SSI increased gradually with increasing BMI. Moreover, 
this association was present in both superficial and deep SSI. However, in partial 
hip prosthesis, obesity was related to superficial and deep SSI, but overweight only 
was a risk factor for deep SSI [32]. Another study had similar findings. It showed 
that members of the Enterobacteriaceae were more common among normal-weight 
patients with hip replacement [33].
On the other hand, among the total knee replacement patients, obesity was a risk 
factor for deep SSI but not for superficial SSI. Indeed, only a BMI > 40 was a risk 
factor for superficial SSI [32].
A meta-analysis also demonstrated that the risk of periprosthetic joint infec-
tion in obese patients was 1.9-fold higher than non-obese patients. The authors 
mentioned that this increased risk could be related to prolonged operative time, 
an increased rate of wound complications, and the presence of medical comor-
bidities [45].
Finally, a large study that included 161,785 patients showed that obesity was 
associated to higher rates of complications after total hip arthroplasty than after 
total knee arthroplasty. The study demonstrated that among the obese and mor-
bidly obese patients who underwent primary total hip replacement, the risk of total 
complications, wound complications, deep infection, and reoperation was higher 
than for similar weighted patients who underwent primary total knee arthroplasty. 
This observed difference would be due to the tendency of the adipose tissue to 
deposit in the gluteal region [46].
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3.4 Obesity and cardiothoracic surgery
Among the patients who undergo cardiothoracic surgery, obesity is a risk factor 
for SSI. Several studies have shown that the risk for SSI augmented gradually with 
increasing BMI [32, 33]. In cardiac surgery, however, an obesity paradox has been 
described. It means that mildly obese or overweight patients may have some benefit 
instead of an increased risk. Indeed, a large study that included 4740 patients who 
underwent cardiac surgery demonstrated that extremely obese (BMI > 40 kg/m2) 
patients had an increased risk for deep sternal infection, prolonged ventilation after 
cardiac surgery, and postoperative renal dialysis requirement. In contrast, mildly 
obese or overweight patients had minor in-hospital mortality, minor operative mor-
tality, and less ICU hours [47]. Another study showed that obesity and underweight 
were both associated to postoperative adverse events. However, this study did not 
show differences between extremely and mildly obese patients probably because 
both studies used different ways to categorize BMI [48].
3.5 Obesity and neurosurgery
A large study performed in the Netherlands failed to demonstrate an associa-
tion between obesity and surgical site infection after laminectomy [32]. However, 
another study which included 31,763 patients demonstrated that complications 
after lumbar spine surgery were associated to obesity. The stratification by BMI 
established five categories: underweight (BMI < 18.5), normal-overweight (BMI 
20.0–29.9), obesity class I (BMI 30.0–34.9), obesity class II (35.0–39.9). and obesity 
class III (BMI > 40). The study evaluated airway, cardiopulmonary, and infectious 
complications. They found that obese class I was associated to 4 of the 11 complica-
tions analyzed; obesity class II was associated to 6 of the 11 complications analyzed; 
and obesity class III was associated to 9 of the 11 complications analyzed. In addi-
tion, the rate of surgical site infection increased with increasing obesity class [49].
The effect of obesity on cranial surgery is similar to spinal surgery, but the 
impact on surgical outcomes is lower on cranial surgery. It increases the risk of 
major medical complications and may increase the risk for SSI after craniotomy. On 
the other side, in spinal surgery, obesity increases the risk of SSI, venous thrombo-
embolism, and major medical complications [50].
4. Conclusion
Although obesity leads to a pro-inflammatory state, it impairs the immune system 
and is a risk factor for several infections. Moreover, in surgical site infection, there are 
local factors related to obesity that must be taken into account: a large adipose panicle 
with poor oxygenation, a reduced operative field, difficulties in technique, and 
increased operative time. Therefore, obesity is a proven risk factor for surgical site 
infection in plenty of surgeries. However, there are some actions that we could take 
to reduce this risk: performing minimal invasive surgery, ensuring adequate surgical 
technique, prescribing adequate antibiotic doses, and recommending weight loss.
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